---
schema_version: "secwatch.filing_event.v1"
accession: "0001005286-23-000037"
form_type: "8-K"
ticker: "LFCR"
cik: "0001005286"
company_name: "LIFECORE BIOMEDICAL, INC. DE"
filed_at: "2023-02-07T23:59:59+00:00"
generated_at: "2026-06-19T22:20:41.099723+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Lifecore Biomedical sells avocado products business for $17.5M cash

## Summary
- Purchase price of $17.5M in cash, subject to post-closing adjustments including net working capital.
- Sale includes Yucatan and Cabo Fresh brands and manufacturing facility in Guanajuato, Mexico.
- Net proceeds used to repay borrowings under existing credit agreements.
- Lifecore retains only O Olive from former Curation Foods segment; continues to grow core business.
- Transition services agreement with buyer for up to three months following closing.

## SEC filing metadata
- accession: 0001005286-23-000037
- form_type: 8-K
- ticker: LFCR
- cik: 0001005286
- company_name: LIFECORE BIOMEDICAL, INC. DE
- filed_at: 2023-02-07T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1005286/000100528623000037/0001005286-23-000037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1005286/000100528623000037/lndc-20230207.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001005286-23-000037
- JSON: https://secwatch.observer/filing/0001005286-23-000037.json
- Plain text: https://secwatch.observer/filing/0001005286-23-000037.txt

## Key facts
- M&A Transactions
  LIFECORE BIOMEDICAL, INC. DE completed a disposition involving Yucatan Acquisition Holdings LLC for $17.5 million in cash (closed 2023-02-07).
  - Action: disposition
  - Counterparty: Yucatan Acquisition Holdings LLC
  - Consideration: $17.5 million in cash
  - Closing: 2023-02-07
  source text: executed by the Parties on February 7, 2023 (the “Securities Purchase Agreement”). Pursuant to the Securities Purchase Agreement, Buyer acquired Yucatan for a purchase price of $17.5 million in cash, subject to certain post-closing adjustments, including net working capital, at closing. Following the Yucatan Disposition, the Company continues to grow its Lifecore
  evidence_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528623000037/0001005286-23-000037-index.htm
- Material Agreements
  LIFECORE BIOMEDICAL, INC. DE entered into Securities Purchase Agreement with Yucatan Acquisition Holdings LLC, Yucatan Foods, LLC, Camden Fruit Corp. (effective 2023-02-07).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: Yucatan Acquisition Holdings LLC, Yucatan Foods, LLC, Camden Fruit Corp.
  - Effective: 2023-02-07
  source text: Securities Purchase Agreement, dated February 7, 2023, by and among Lifecore Biomedical, Inc., Yucatan Foods, LLC, Camden Fruit Corp., and Yucatan Acquisition Holdings LLC.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528623000037/0001005286-23-000037-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.